Skip to main content
SpringerLink
Log in

The implementation of nucleic acid amplification technology testing for living tissue donors

  • Published:
Cell and Tissue Banking Aims and scope Submit manuscript

Abstract

There is a significant requirement within the United Kingdom for tissue grafts from living donors. To ensure safety, blood samples from these donors are tested for pathogens at donation, and at 180 days post donation. Nucleic acid amplification technology (NAT) permits more sensitive detection of pathogens in blood samples than serum antigen testing. NAT testing can be applied to samples from living tissue donors to eliminate the need to re-test these donors 180 days post-donation before grafts can be implanted. This has major financial and operational advantages for a tissue bank, and this manuscript describes how NAT testing was assessed and implemented by NHSBT Tissue Services. When compared to traditional serum antigen testing, NAT testing was more cost effective, more convenient for donors and resulted in a greater proportion of donated grafts being made available for transplant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Busch MP (2007) Evolving approaches to estimate risks of transfusion-transmitted viral infections: incidence-window period model after 10 years. In: Dax EM, Farrugia A, Vyas GN (eds) Advances in transfusion safety—volume IV, vol 127. Developments in Biologicals, Karger, pp 87–112

    Google Scholar 

  • Commission Directive (2006) Available via http://www.dh.gov.uk/en/Publichealth/Scientificdevelopmentgeneticsandbioethics/Tissue/Tissuegeneralinformation/DH . Accessed 23 March 2009

  • Gie GA, Linder L, Ling RS, Simon JP, Slooff TJ, Timperley AJ (1993) Impacted cancellous allografts and cement for revision total hip arthroplasty. J Bone Joint Surg Br 75(1):14–21

    CAS  PubMed  Google Scholar 

  • James V (2005) Chapter 10 Microbiology tests for donors and donations: general specifications for laboratory test procedures. In: James V (ed) TSO, London Guidelines for the blood Transfusion Services in the United Kingdom, 7th edn, pp 137–141

  • Lee SH, Tseng SC (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303–312

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank NHSBT Brentwood Testing Laboratory, especially Steven Tassen for all their hard work, which enabled NAT testing to be implemented with TS.

Author information

Authors and Affiliations

  1. National Health Service Blood and Transplant (NHSBT) Tissue Services, Estuary Banks, Speke, Liverpool, L24 8RB, UK

    J. Westby, R. J. Lomas & J. N. Kearney

Authors
  1. J. Westby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. J. Lomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. N. Kearney
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Westby.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westby, J., Lomas, R.J. & Kearney, J.N. The implementation of nucleic acid amplification technology testing for living tissue donors. Cell Tissue Bank 11, 205–208 (2010). https://doi.org/10.1007/s10561-009-9156-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10561-009-9156-x

Keywords

Search

Navigation